Your browser doesn't support javascript.
loading
Statin Intolerance.
Brown, Alan S; Watson, Karol E.
Affiliation
  • Brown AS; Division of Cardiology, Advocate Heart Institute at Advocate Lutheran General Hospital, Park Ridge, IL.
  • Watson KE; Departments of Medicine & Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Rev Cardiovasc Med ; 19(S1): S9-S19, 2018.
Article in En | MEDLINE | ID: mdl-30207553
ABSTRACT
Statins are critical medications to prevent and treat cardiovascular disease2 and they are generally very well tolerated. In some instances, however, statin intolerance may limit use of these lifesaving medications. Statin intolerance has many definitions but is commonly diagnosed when a patient is unable to continue statin therapy due to perceived, or objectively documented, adverse effects. A very high rate of discontinuation of statin therapy warrants a closer look at the implications from the standpoint of cardiovascular risk in statin-intolerant patients, as well as an evaluation of the available options to help patients maintain their statin therapy and understand the potential benefits of such therapy.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Dyslipidemias / Cholesterol, LDL Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Rev Cardiovasc Med Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2018 Type: Article Affiliation country: Israel

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Dyslipidemias / Cholesterol, LDL Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Rev Cardiovasc Med Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2018 Type: Article Affiliation country: Israel